Pharmamedic Consultancy Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 07364364 (England and Wales)

Unaudited Financial Statements for the Year Ended 30th September 2019

for

Pharmamedic Consultancy Limited

Page

Balance Sheet

1

Notes to the Financial Statements

3

FIXED ASSETS

Tangible assets

4

2,356

3,739

CURRENT ASSETS

Debtors

5

227,414

196,232

Cash at bank

5,118

36,926

232,532

233,158

CREDITORS

Amounts falling due within one year

6

162,490

214,702

NET CURRENT ASSETS

70,042

18,456

TOTAL ASSETS LESS CURRENT LIABILITIES

72,398

22,195

CREDITORS

Amounts falling due after more than one year

7

63,571

13,914

NET ASSETS

8,827

8,281

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

8,727

8,181

SHAREHOLDERS' FUNDS

8,827

8,281

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th September 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th September 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit & Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 18th June 2020 and were signed by:

Dr M F Barratt-Johnson - Director

1.	STATUTORY INFORMATION

Pharmamedic Consultancy Limited is a private company, limited by shares , registered in England and Wales.

The company's registered number and registered office address are as below:

Registered number:

07364364

Registered office:

The London Bioscience Innovation Centre

2 Royal College Street

London

NW1 0NH

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities"

of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of

Ireland" and the Companies Act 2006.

Turnover

Turnover represents the total invoice value, excluding value added tax, of sales made during the year.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Computer equipment

-

Straight line over 4 years

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit & Loss Account, except

to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the

lease.

Going concern

The balance sheet at the end of the year recorded net liabilities. However, the director believes that sufficient

financial resources are available to the company to enable it to continue trading into the foreseeable future.

Therefore, the financial statements have been prepared on a going concern basis.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2018 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1st October 2018

and 30th September 2019

6,821

DEPRECIATION

At 1st October 2018

3,082

Charge for year

1,383

At 30th September 2019

4,465

NET BOOK VALUE

At 30th September 2019

2,356

At 30th September 2018

3,739

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Trade debtors

11,203

78,253

Amounts owed by group undertakings

-

1,428

Other debtors

216,211

116,551

227,414

196,232

The debts that were subject to invoice discounting for the company at the year end amounted to £6,324 (2018:

£58,590)

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2019

2018

£

£

Trade creditors

21,649

32,280

Taxation and social security

82,447

83,150

Other creditors

58,394

99,272

162,490

214,702

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2019

2018

£

£

Other creditors

63,571

13,914

8.	SECURED DEBTS

The following secured debts are included within creditors:

2019

2018

£

£

Invoice discounting

4,079

36,020

The invoice discounting is secured over the fixed and floating charge over all the assets of the business.

9.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2019 and

30 September 2018:

2019

2018

Director 1

£

£

Amounts advanced

106,494

163,061

Amounts repaid

(75,418

)

(172,017

)

Interest was charged on all loans at HMRC approved rates.